United States · FDA National Drug Code directory
Juluca
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49702-242_19269bd8-a858-414a-80b5-9acba5aa9fd7
- Product NDC
- 49702-242
- Form
- TABLET, FILM COATED
- Composition / generic term
- dolutegravir sodium and rilpivirine hydrochloride
- Labeler
- ViiV Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20171121
- Source listing expiry
- 20271231
Source-listed ingredients
- DOLUTEGRAVIR SODIUM — 50 mg/1
- RILPIVIRINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (49702-242-13) · 49702-242-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →